ITGBL1 and neoplasm: A previous study has suggested that ITGBL1 is a novel immunomodulator that promotes tumor development by inhibiting the cytotoxicity of NK cells.9 Subsequently, we further analyzed the correlation between ITGBL1 and different tumor-infiltrating immune cells according to the TIMER database.